In this 2-minute audio snippet, Silja Chouquet, Owner at whydot GmbH, suggests that pharmaceutical companies should stop trying to market brands via Twitter and focus on using it to support patients.
Silja was speaking at "The Future of Branding is #Now" 6th Ideagoras-BBVA International Conference on Innovation and Collaborative Branding (November 6, 2014).
Silja's presentation - "Pharma's DNA on Twitter" - is embedded below. It contrasts Twitter use by Novartis and Boehringer Ingelheim:
Want To Be Interviewed?
Pharmaguy is interested in conducting 5-minute interviews with authors, conference speakers, consultants, pharma brand managers, and anyone else who has an interesting story or point of view relating to the pharmaceutical industry. You can even be anonymous, if necessary. If the topic warrants more than 5 minutes, we can take it up a notch on Pharma Marketing Talk.
Please fill out the following form (or click here) if you would like to request an interview with Pharmaguy. Make sure you check "Request for Interview" as the Topic. Thanks.